Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rojas

Showing results (521-530 of 584) with videos related to

Pageof 59
Sort By:
Journal of Alzheimer'S Disease : JAD|July 30, 2025
Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Frontiers in Aging Neuroscience|December 6, 2024
Preliminary reference values for Alzheimer's disease plasma biomarkers in Congolese individuals with and without dementiaJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Alzheimer'S Research & Therapy|September 22, 2023
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairmentNidhi S Mundada, Julio C Rojas, Lawren Vandevrede, et al.
Journal of Alzheimer'S Disease : JAD|September 28, 2020
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease StageBreton M Asken, Fanny M Elahi, Renaud La Joie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 15, 2024
Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementiasElena Tsoy, Renaud La Joie, Lawren VandeVrede, et al.
Frontiers in Neurology|April 11, 2024
Sensitivity of the African neuropsychology battery memory subtests and learning slopes in discriminating APOE 4 and amyloid pathology in adult individuals in the Democratic Republic of CongoJean Ikanga, Sarah D Patrick, Megan Schwinne, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Neurodegenerative Plasma Biomarkers for Prediction of Hippocampal Atrophy in Older Adults with Suspected Alzheimer's Disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectoryPeter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2025
Combining plasma neurofilament light chain and frontotemporal atrophy improves differentiation of bvFTD from primary psychiatric disordersSean Coulborn, Ashlin R K Roy, Andrzej Sokolowski, et al.
Critical Care Explorations|October 30, 2025
The Epidemiology of ICU Readmissions Across Ten Health SystemsSaki Amagai, Vaishvik Chaudhari, Kaveri Chhikara, et al.
Pageof 59

Showing results (521-530 of 584) with videos related to

Sort By:
Pageof 59
Journal of Alzheimer'S Disease : JAD|July 30, 2025
Neurodegenerative plasma biomarkers for prediction of hippocampal atrophy in older adults with suspected Alzheimer's disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Frontiers in Aging Neuroscience|December 6, 2024
Preliminary reference values for Alzheimer's disease plasma biomarkers in Congolese individuals with and without dementiaJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Alzheimer'S Research & Therapy|September 22, 2023
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairmentNidhi S Mundada, Julio C Rojas, Lawren Vandevrede, et al.
Journal of Alzheimer'S Disease : JAD|September 28, 2020
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease StageBreton M Asken, Fanny M Elahi, Renaud La Joie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 15, 2024
Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementiasElena Tsoy, Renaud La Joie, Lawren VandeVrede, et al.
Frontiers in Neurology|April 11, 2024
Sensitivity of the African neuropsychology battery memory subtests and learning slopes in discriminating APOE 4 and amyloid pathology in adult individuals in the Democratic Republic of CongoJean Ikanga, Sarah D Patrick, Megan Schwinne, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Neurodegenerative Plasma Biomarkers for Prediction of Hippocampal Atrophy in Older Adults with Suspected Alzheimer's Disease in Kinshasa, Democratic Republic of CongoJean Ikanga, Kharine Jean, Priscilla Medina, et al.
Annals of Clinical and Translational Neurology|October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectoryPeter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 8, 2025
Combining plasma neurofilament light chain and frontotemporal atrophy improves differentiation of bvFTD from primary psychiatric disordersSean Coulborn, Ashlin R K Roy, Andrzej Sokolowski, et al.
Critical Care Explorations|October 30, 2025
The Epidemiology of ICU Readmissions Across Ten Health SystemsSaki Amagai, Vaishvik Chaudhari, Kaveri Chhikara, et al.
Pageof 59